MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Serum molecular markers and non-motor symptoms in Parkinson’s disease

I. González-Aramburu, M. Sierra, J. Infante, S. Jesús Maestre, M. Aguilar, P. Pastor, J. Hernández Vara, S. Escalante, F.J Carrillo Padilla, M. Pueyo, J.M García Moreno, V. Puente, A. Crespo Cuevas, O. de Fábregues-Boixar, B. Solano Vila, T. de Deus-Fonticoba, P. Martínez Martín, P. Mir, D. Santos García (Santander, Spain)

Meeting: MDS Virtual Congress 2020

Abstract Number: 716

Keywords: Non-motor Scales

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: The aim of this study was to examine the association between several serum molecular markers and different measures of non-motor symptom burden in PD.

Background: There is a need of biomarkers associated with PD progression as well as with motor and non-motor features. Serum molecular markers are easily accessible and therefore have been examined for this purpose, yielding conflicting results.

Method: Patients participating in the COPPADIS-2015 study that performed blood extraction at baseline for determining molecular serum biomarkers were included. Blood sample collection for the determination of different serum biomarkers included S-100b protein, tumor necrosis factor (TNF)-ɑ, interleukin (IL)-1, IL-2, IL-6, vitamin B12, methylmalonic acid (MMA), homocysteine, uric acid, ultrasensitive CRP, ferritin, and iron. In the moment of sample collection, PD patients underwent a battery of clinical assessment to evaluate symptom severity, including motor (UPDRS, HY) and non-motor assessments (MMSE, PD-CRS, NMSS, BDI-II, NPI, QUIP-RS, PDSS, VAS-Pain, VASF-physical, VASF-mental). Univariate correlation analysis and multivariate general linear models were created, controlling for confounding variables, and were used to determine whether serum markers are associated with various symptom outcome measures.

Results: The sample consisted of 225 PD patients, mean age 61.8 years, mean disease duration 5.6 years. A significant correlation was observed between baseline serum ferritin levels and NMSS score (r= -0.24; p= 0.001). Subjects with higher non-motor symptom burden also had lower levels of ferritin (p= 0.03). We also observed a significant correlation between serum MMA levels and QUIP-RS score (r= 0.22; p=0.001). In this sense, the subjects with impulsive compulsive behaviour also had higher levels of MMA (p=0.004). The rest of the serum markers analyzed did not show significant associations with the load of non-motor symptoms measured by the different scales after correcting for confounders and multiple testing.

Conclusion: There are indications of an association, albeit weak, between serum levels of ferritin and methylmalonic acid with non-motor symptom burden and impulsive compulsive behavior, respectively, in PD. The prospective follow-up of this cohort will allow us to know whether these are useful biomarkers in Parkinson’s disease.

To cite this abstract in AMA style:

I. González-Aramburu, M. Sierra, J. Infante, S. Jesús Maestre, M. Aguilar, P. Pastor, J. Hernández Vara, S. Escalante, F.J Carrillo Padilla, M. Pueyo, J.M García Moreno, V. Puente, A. Crespo Cuevas, O. de Fábregues-Boixar, B. Solano Vila, T. de Deus-Fonticoba, P. Martínez Martín, P. Mir, D. Santos García. Serum molecular markers and non-motor symptoms in Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/serum-molecular-markers-and-non-motor-symptoms-in-parkinsons-disease/. Accessed May 24, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/serum-molecular-markers-and-non-motor-symptoms-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley